Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Capricor Therapeutics
Biotech
Capricor culls COVID-19 vax work, readies for phase 3 DMD trial
Capricor will get enrollment underway in a phase 3 trial for its DMD cell therapy next quarter, while a COVID-19 vaccine is coming to a halt.
Kyle LaHucik
Mar 11, 2022 8:00am
Capricor, Nippon ink $705M biobucks deal for phase 3 DMD therapy
Jan 25, 2022 5:00am
Capricor finds efficacy in older Duchenne patients in phase 2
Sep 24, 2021 7:00am